Conversely, findings from previous studies suggest that continuous activation of antioxidant Nrf2 may be beneficial to the growth of cancer cells, and may become a way for cancer cells to escape the attack of chemotherapy drugs, providing conditions for cancer cells to develop drug resistance [7, 10–12]. Here, NFE2L2 is linked to cancer.